Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hearts of Iron IV Eastern Expansion Date Set

No Step Back Add-on Tapped for Late NovemberSTOCKHOLM - 21 October, 2021 - The bitter fighting of the Eastern Front is given new depth and variety in No Step Back, the upcoming expansion to Hearts of Iron IV. With new alternate history paths and game systems, this eagerly awaited add-on presents new challenges for fans of Paradox Interactive’s best-selling grand strategy wargame. No Step Back will be available on 23 November, 2021. It will be available for the suggested retail price of $19.99/￡15.49/€19.99. The centerpiece of No Step Back is a series of new National Focus Trees, giving

Atea ASA - share buyback

Oslo, 21 October 2021, Please see below information about transactions made under the share buyback programme for Atea ASA. Date on which the buyback programme was announced: 17 September 2021 The duration of the buyback programme: 20 September 2021 to 31 October 2021 Size of the buyback programme: Up to 520,000 shares From 15 October 2021 until 21 October 2021, Atea ASA has purchased a total of 86,000 own shares at the Oslo Stock Exchange at an average price of NOK 151.84 per share. Following the completion of the above transactions, Atea ASA owns a total of 893,000 own

Bulletin from the Extraordinary General Meeting in Handelsbanken on 21 October 2021

An Extraordinary General Meeting in Svenska Handelsbanken AB was held today, 21 October 2021.The Extraordinary General Meeting resolved in accordance with the Board’s proposals on: a) approving that Handelsbanken enter into an agreement on the acquisition of a total of 30,461,977 class A shares in AB Industrivärden (“Industrivärden”) from Svenska Handelsbankens Pensionsstiftelse and b) the distribution of the thus acquired class A shares in Industrivärden to the shareholders of Handelsbanken. The record date for the distribution was resolved to be 25 October 2021. The last trading day in

ContextVision – Mandatory notification of trade – primary insider

STOCKHOLM – October 21, 2021 – Martin Ingvar, Member of the Board of ContextVision, has on October 21, 2021 purchased 6,000 shares in ContextVision AB at an average price of NOK 22.10 per share. After the transaction, Mr Ingvar holds a total of 12,000 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision ABISIN number: SE0014731154Stock ticker: CONTXName of primary insider: Martin IngvarRelation to listed entity: Member of the

#21-346 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Modus Therapeutics engages Lago Kapital as a liquidity guarantor

STOCKHOLM, SWEDEN - 21 October 2021: Modus Therapeutics Holding AB (“Modus Therapeutics”) announces that it has engaged Lago Kapital as a liquidity guarantor for the company's share. The liquidity guarantee starts to run from 22 October 2021.In its assignment as liquidity guarantor, Lago Kapital will ensure the opportunity to trade in the company's shares by continuously placing trading items on each buy and sell page in the order book. This is in accordance with Nasdaq First North Growth Market regulations regarding liquidity guarantee and means that the liquidity guarantor quotas the

Nomination Committee

According to the principles for the appointment of the Nomination Committee adopted by the 2020 Annual General Meeting, the Chairman of the Board of Directors shall annually and not later than the end of the third quarter every year, convene the three largest shareholders in the company, as registered at August 31 according to Euroclear Sweden AB, which are then each entitled to appoint one member of the Nomination Committee. In addition to the above, the Chairman of the Board can also be a member of the Nomination Committee. The mandate period of the Nomination Committee extends until such

Interim report January - September 2021

In the interim report for January to September, VBG Group reports continued strong sales and increased focus on growth.Third quarter 2021 · Consolidated sales increased 11.7% to SEK 848.3 M (759.6). · Adjusted for exchange rate changes between the years, actual organic volume growth was 19.5%. · Operating profit amounted to SEK 110.5 M (113.0). · The operating margin was 13.0% (14.9). · Profit after financial items increased to SEK 107.4 M (100.0). · Earnings per share amounted to SEK 3.29 (2.95). Nine months 2021 · Consolidated sales increased by 12.1% to SEK 2,

Neonode Announces $14 Million Registered Direct Offering

STOCKHOLM, SWEDEN, October 21, 2021 — Neonode Inc. (NASDAQ: NEON), today announced it has agreed to place with certain Swedish and European investors 1,808,000 shares of its common stock at a purchase price of $7.75 per share in a registered direct offering. The closing of the offering is expected to occur on or about October 25, 2021, subject to the satisfaction of customary closing conditions. The Company plans to use the net proceeds from the offering for continued investments in sales and marketing to create greater awareness and drive demand for contactless touch and Neonode’s Touch

Driven by a passion to improve patients’ quality of life

Curiosity and continuous learning have always been some of Andres Beiras’ ground principles in life. He used to spend every day in the operating room and the lab, and today he is part of the team that develops the very same therapies and solutions that made his job as a cardiac surgeon and scientist possible. Before joining Getinge, Andres Beiras worked as a cardiac surgeon driven by a strong passion to give patients the best possible chance to get back to a normal life. “People often ask me what it is like to save someone’s life. I’ll tell you what, it feels much better than

Klarna partners with Wix, bringing flexible payment solutions to merchants worldwide

Wix eCommerce merchants across 17 countries can now accept payments from their customers with Klarna, the global leader in alternative payment options New York, NY (October 21, 2021) — Klarna , the leading global retail bank, payments, and shopping service, today announced a strategic partnership with Wix  (Nasdaq: WIX), a leading global SaaS platform to create, manage and grow an online presence. Together, Wix and Klarna will bring flexible, convenient payment options to Wix eCommerce  merchants across

Read original

Extraordinary General Meeting in Skandinaviska Enskilda Banken AB on 12 November 2021

The Board of Directors of Skandinaviska Enskilda Banken AB has as previously communicated decided to propose a further ordinary dividend of SEK 4.10 per share. As a result, the Board of Directors will convene an Extraordinary General Meeting on 12 November 2021. Due to the pandemic and the uncertainties that still remain, the Board of Directors has decided that the Extraordinary General Meeting shall be conducted without the physical presence of shareholders, proxies or third parties and that shareholders shall have the opportunity to exercise their voting rights by postal voting in

Invitation to Q3 Earnings Teleconference

Karnov Group (Nasdaq: KAR) will publish its financial report for the third quarter and first nine months 2021 on 4 November at around 8.00 CET and Management will host a webcasted telephone conference the same day at 10.00 a.m. CET.Karnov Group’s interim report for the period January – September 2021 will be published on Thursday 4 November 2021 at around 8.00 a.m. CET. A webcasted telephone conference will be held at 10.00 a.m. CET the same day, where CEO Pontus Bodelsson and CFO Dora Brink Clausen will present the report and answer questions. You can follow the presentation via webcast

Strong increase in market prices cause Fortum subsidiary Uniper to raise profit guidance for 2021 and to record major negative accounting effect

FORTUM CORPORATION INSIDE INFORMATION 21 OCTOBER 2021 AT 15:53 EEST Fortum’s subsidiary Uniper SE has today published a stock exchange release (‘ad-hoc’) with a positive update of its result guidance for 2021. According to Uniper, the increase in the earnings is mainly due to the continuous and strong increase in commodity prices – especially in European gas and power market reflecting mainly a higher contribution from the gas mid-stream business within Uniper’s Global Commodities business. The company has also recorded a major negative effect from changes of fair values of non-hedge-

Keystone Creates Largest European US College Sports Student-Athlete Placement Agency

Three leading European student athlete placement agencies combined to create Keystone Sports  Oslo, Norway – 21 October 2021  The Keystone Education Group (Keystone) has announced the launch of Keystone Sports, a placement agency that matches European student-athletes with colleges and universities in the United States.    The announcement comes as Keystone completes the acquisition of its third US college student-athletics placement firm in recent months, Sport-Scholarships KEG GmbH (Sport-Scholarships), following previous acquisitions of Athletes Global Management (AGM)

Block_001 - News and ongoing updates from JS Security

Dear shareholders, We have a lot of exciting things going on and are now ready to continuously start communicating events in the company in a new format. Recently, great focus has been placed on development and dialogues with stakeholders, potential partners, and potential customers. After months of hard work, we have built a long-term team that will drive our vision and product range forward. We have very exciting information that we want to share with the market according to a previously communicated strategy. We have developed a process and a format that makes it easier for

Alligator Bioscience AB: Correction regarding MAR marking

The press release as of October 21, 2021 regarding the Interim report January – September 2021 incorrectly contained a so-called MAR marking. This was not the company's intention, as the information is not to be regarded as inside information. For further information, please contact: Julie Silber, Investor RelationsPhone: +46 46-540 82 23E-mail: jur@alligatorbioscience.com About Alligator Bioscience Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. The pipeline includes two clinical assets: mitazalimab,

Invitation to Q3 2021 webcast

Zalaris ASA will release its third quarter 2021 results on Thursday 28 October 2021.Zalaris will host a webcast for all shareholders and interested parties on 28 October at 08:30 CET. There will be a Q&A session following the management presentation. Link to webcast will be available on ir.zalaris.com. Contact: Gunnar Manum, CFOMobil: +47 95 17 91 90 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

News conference on Kojamo’s Interim Report for January–September 2021 on 4 November 2021

Kojamo plc Press Release, 21 October 2021 at 3:00 p.m. EESTNews conference on Kojamo’s Interim Report for January–September 2021 on 4 November 2021 Kojamo plc’s Interim Report for January–September 2021 will be published on Thursday, 4 November 2021 at approximately 8:00 a.m. EEST. News conference and webcast Kojamo will hold a news conference for institutional investors, analysts and media on 4 November 2021 at 10:00 a.m. at its headquarters at Mannerheimintie 168A, Helsinki, Finland. The event will be hosted by Kojamo’s CEO Jani Nieminen and CFO Erik Hjelt, and it will be held in

Volati continues to grow through the acquisition of Meag Va-system

Volati has signed an agreement to acquire all shares in Meag Va-system, a leading provider of concrete solutions for water and sewage infrastructure. The acquisition is an add-on acquisition for the S:t Eriks business unit in the Industry business area. The acquisition significantly strengthens S:t Eriks’ market position in water and sewage infrastructure and adds both new product ranges and production capacity. Meag Va-system reported sales of approximately SEK 190 million for the last financial year. The acquisition of Meag Va-system is Volati’s seventh acquisition of 2021 and the

Alma Media begins buyback of its own shares for share-based incentive scheme

Alma Media Corporation   Stock exchange release    21 October 2021 at 3 pm Alma Media Corporation’s Board of Directors has decided to use the buyback authorisation of Alma Media’s shares granted by the Annual General Meeting on 24 March 2021. The buyback programme will be initiated at the earliest on 22 October 2021 and terminated once all the shares have been purchased. The number of shares to be acquired is a maximum of 320,000 shares, which represents approximately 0.4 per cent of all Alma Media shares. The acquired shares will be used to implement the company’s share-based incentive

Genovis announces exclusive license agreement with Selecta Bioscience to develop and promote a novel IgG Protease in Gene Therapy and Autoimmune Disease

Under the agreement Genovis grants Selecta exclusive license to develop and promote a proprietary IgG protease, Xork™, as a potential pre-treatment prior to the administration of gene therapy and for autoimmune diseases.  Under the terms of the license: · Genovis will receive USD 6 million in upfront and early preclinical milestone payments and is eligible for up to USD 598 million in development, regulatory and sales milestone payments. Additionally, Genovis will receive double digit royalties on sales. · Genovis will retain its rights to the Xork enzyme for all applications

BE Group Q3 2021

Third quarter · Net sales increased by 85% to SEK 1,375 M (744) · The underlying operating result increased to SEK 193 M (14) · Inventory gains and losses amounted to SEK 26 M (-10) · The operating result increased to SEK 219 M (4) · Result after tax increased to SEK 175 M (-4) · Cash flow from operating activities increased to SEK 6 M (1) · Earnings per share increased to SEK 13.49 (-0.32) Statement from the CEONormally, the third quarter is a weak quarter for BE Group, but continued higher demand combined with rising steel prices and higher gross margins means

“Planmeca stands out with the level of customer service”

Aesthetic dentistry can help you achieve teeth and smile that are not only beautiful to look at but also beneficial for the overall health. Dr Nobuya Kitahara, one of the most acclaimed specialists in the field of dental aesthetics in Japan, has been working over 30 years to improve the oral health of the Japanese. To ensure the best possible treatment results, he relies on Planmeca products. Dr Nobuya Kitahara, DDS, is a specialist in aesthetic restorative dentistry and prosthodontics. He runs the TEAM TOKYO Nobu Restorative Dental Office in the heart of Tokyo, near the famous

There are no items matching the current filter
There are no more items matching the current filter
Back to top